User banner image
User avatar
  • admin

Posts

Li-S Energy collaborates with Kea Aerospace to power high altitude UAV flights

SYDNEY, March 31, 2025 /PRNewswire/ — Li-S Energy (ASX:LIS) (‘Li-S’ or ‘the Company’) has signed a collaboration agreement with Kea Aerospace (Kea) to integrate Li-S’...

CNOOC Limited Announces A Hundred-Million-Ton Oilfield Discovery of Huizhou 19-6

HONG KONG, March 31, 2025 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that the Company...

Patent Index 2024: Japan ranks 3rd in European patent applications

European Patent Office received nearly 200 000 patent applications last year, with Japanese companies and inventors filing 10.6% of the total Electrical machinery/energy, transport and...

Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179’s Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification

Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to utilize BRII-179 to identify patients who are immune responders and...

Tourism Plus Shanghai 2025, a Key Innovation Hub of Global Tourism Industry, to Break Record with its Scale

SHANGHAI, March 28, 2025 /PRNewswire/ — From March 30th to April 3rd, Tourism Plus Shanghai 2025 (TPS2025) will set a new historical record with 5...

Charge Up, SEA! Anker Powers Iconic Landmarks Across Southeast Asia With Immersive AR Campaign

HO CHI MINH CITY, Vietnam, March 30, 2025 /PRNewswire/ — Anker Innovations, a global leader in mobile charging and consumer electronics, is redefining the boundaries of...

ROSEN, LEADING TRIAL ATTORNEYS, Encourages e.l.f. Beauty, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELF

NEW YORK, March 29, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc....

Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk

–Data presented at the American College of Cardiology Annual Scientific Session show that the reduction of bleeding with abelacimab compared to rivaroxaban (Xarelto) was even...

ProDentim Reviews (EXPOSED): Why 75,000+ Americans Are Replacing Mouthwash with This ProDentim Chewable Tablet

Discover the Oral Probiotic That’s Reshaping Dental Health—Backed by 75,000+ Users and Groundbreaking Science VANCOUVER, WA, March 29, 2025 (GLOBE NEWSWIRE) —  ProDentim reviews In...

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL...